EN | RU
EN | RU

Help Support

Back

Rapid-acting Acetaminophen triumphs in dental pain study

dental pain relief dental pain relief
dental pain relief dental pain relief

What's new?

Rapid-acting Acetaminophen 1000 mg is effective for quick pain relief, with no notable side effects.

According to a novel study issued in ‘Current Medical Research Opinion’, fast/rapid-acting Acetaminophen (RA-Acetaminophen) was proven to have a quicker onset of pain relief compared to extra-strength Acetaminophen and liquid-filled Ibuprofen capsules.

In response to the demand for quicker pain relief among over-the-counter analgesic (oral Acetaminophen) users, a new drug delivery technology was created to enhance the absorption rate of the analgesic for a swifter onset of pain relief. This clinical trial by Andrew Myers et al. compared the onset of pain relief of RA-Acetaminophen with other analgesics available over-the-counter i.e. Ibuprofen 400 mg (liquid filled capsules, LG-Ibuprofen) or Acetaminophen (ES-Acetaminophen) 1000 mg extra-strength. Overall, 664 people (mean age=18.9 years; 45.5% men; 57.5% had severe baseline pain intensity) with moderate-to-severe pain after the surgical removal of 3-4 impacted third molars. They were randomized in a 4:4:2:1 ratio to receive RA-Acetaminophen 1000 mg (249 people), ES-Acetaminophen (232 people) 1000 mg, LG-Ibuprofen (124 people) 400 mg, or placebo (59 people).

RA-Acetaminophen outshined other pain-relief options with a quicker median time to start pain relief (15.7 min) than ES-Acetaminophen (20.2 min, p = 0.035), LG-Ibuprofen (23.2 min, p < 0.001) and placebo. It also displayed statistically superior mean pain intensity difference (PID) and pain relief (PAR) scores (numerical rating scale) than other groups at 15 and 30 minutes. A statistically greater number of people with definite perceptible pain relief at 15 and 20 minutes was also noticed with the use of RA-Acetaminophen. RA-Acetaminophen showed a considerably higher percentage of people experiencing noticeable pain relief than those taking LG-Ibuprofen 400 mg and the placebo. There were no reports of clinically noteworthy adverse events.

Source:

Current Medical Research Opinion

Article:

Clinical validation of a fast-acting Acetaminophen : a randomized, active and placebo controlled dental pain study

Authors:

Andrew Myers et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: